Evoq Remedies Company was formed in the year 2010, Company started its operations in the year 2018 onwards. The Company is one of the recognized trading house of Pharmaceuticals RawMaterials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. Which procure the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on our first-class distribution expertise.

Bidding Dates
17 Mar 2022 - 22 Mar 2022
Subscription
1.67x Oversubscribed
Minimum InvestmentMinimum LotMaximum LotLot SizeNumber of SharesIssue PricePost Issue Promoter Holding %Issue SizeIPO Document
₹1,08,0001140003.6 M₹2773.53 %₹97.2 MRHP DOC

Evoq Remedies IPO SUBSCRIPTION STATUS

22 Mar '22
Total1.67x
Retail Individual Investor3.03x
HNI (NII) Investors0.3x
Qualified Institutional Buyers-

Evoq Remedies IPO overall subscription rate was 1.67 times the total available shares

Evoq Remedies IPO retail subscription rate was 3.03 times in the retail segment

Evoq Remedies IPO non-institutional investor subscription rate was 0.3 times in the non-institutional investor category

DayRetail Individual InvestorHNI (NII) InvestorsQualified Institutional Buyers
Category Reservation50%50%-
21 Mar 2022
(Day 2)
1.12x0.27x-
22 Mar 2022
(Day 3)
3.03x0.3x-
17 Mar 2022
(Day 1)
0.26x0.11x-

Evoq Remedies FINANCIALS

Period Net Profit (Rs in millions) Revenue from operations (Rs in millions) Cash Flow from operations (Rs in millions) Free Cash flow (Rs in millions)
11MFY22 9.4 105.7 -153.9 -153.9
FY21 7.1 100.2 0.3 0.3
FY20 0.0 90.7 -0.2 -0.2
FY19 0.1 32.5 0.1 0.1

Evoq Remedies IPO SUBSCRIPTION STATUS DETAILS

Evoq Remedies had 3.6 M shares on offer

Evoq Remedies IPO offer price was ₹27

Evoq Remedies IPO minimum Investment was108000

Evoq Remedies IPO issue size was ₹ 97.2 M

Evoq Remedies had a minimum lot size of 4000 Shares per application

Evoq Remedies NUMBER OF SHARES ON OFFER

Total3.6 M
Fresh Issue3.6 M
Offer for Sale0
Post Issue Promoter Holding %73.53 %

Evoq Remedies IPO IMPORTANT DATES

Issue Open Date17 Mar 2022
Issue close Date22 Mar 2022
Allotment Date25 Mar 2022
Refund Date28 Mar 2022
Demat Account Credit Date29 Mar 2022
Listing Date30 Mar 2022
Listing on Exchange(s)BSE
Evoq Remedies Allotment StatusExchange

Evoq Remedies IPO subscription opened on 17 Mar 2022, and closed on 22 Mar 2022

IPO allotment for Evoq Remedies was finalized on Friday, 25 Mar 2022

IPO listing for Evoq Remedies was on BSE on Wednesday, 30 Mar 2022

Evoq Remedies IPO LISTING GAINS

Issue Price (adjusted)27.0
Listing Open Price25.0
Listing Close Price23.8
Listing Gain%-7.4%
Current Gain%-92.9%

Evoq Remedies Peer

StockStock PriceMarket Cap (Rs crore)PE TTMPEG TTMPS TTMROE%ROA%Annual Revenue (Rs crore)Annual Revenue Growth %Annual Net Profit (Rs crore)Annual Net Profit Growth %EPS TTMEPS TTM Growth %
Evoq Remedies Ltd.1.92.6-19.90.10.1-0.5-0.526.888.8-0.2-372-0.1-248.6
Poly Medicure Ltd.1693.817168.354.5-4.68.610.48.21995.313.4322.1-4.831.1-11.9
Medplus Health Services Ltd.700.28412.6402.21.211.15.66963.812.6219.646.117.518
Q-Line Biotech Ltd.538.71256.722.622.610347.47.755.798.123.9
Laxmi Dental Ltd.216.11187.641-4.74.311.99.8286.418.129-8.85.3-8.8
Vasa Denticity Ltd.408.6679.168.5-2.22.35.75283.412.89.9-41.66-31.3

Evoq Remedies INFORMATION ON IPO ISSUE

About Evoq Remedies

Evoq Remedies Company was formed in the year 2010, Company started its operations in the year 2018 onwards. The Company is one of the recognized trading house of Pharmaceuticals RawMaterials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. Which procure the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on our first-class distribution expertise. 

Object of the Issue

  1. To meet incremental working capital requirements
  2. General corporate purpose
  3. To meet public issue expenses

Evoq Remedies - PROMOTERS

Name
Bhumishth Narendrabhai Patel
Payal Bhumishth Patel

Evoq Remedies Lead Manager

Swastika Investmart Limited

merchantbanking@swastika.co.in

Evoq Remedies Registrar to the Offer

Bigshare Services Private Limited

ipo@bigshareonline.com

Evoq Remedies Strengths

Experienced team

The company has an experienced management team

Strength

Continue to develop client relationships and trust

The company seeks to build on existing relationships and also focus on building new relationships

Strength

Evoq Remedies Risks

Defaulters

Promoters, promoter group members and group companies have defaulted in repayment of dues

Risk

Dependent on one state

The company generates entire sales from operations in Gujarat especially in Ahmedabad region

Risk

IPO FAQs

  • Evoq Remedies Ltd. IPO listing opened at Rs 25.00 while the issue price was Rs 27.00 giving -7.41% returns. After adjusting for subsequent bonus and splits, the stock trades at Rs 27.00 giving -92.89% gains since its IPO listing.

  • The promoters of the company are Bhumishth Narendrabhai Patel and Payal Bhumishth Patel.

  • The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.

  • The price band of the IPO is Rs 27.0 - 27.0.

  • The IPO application opens on Mar 17, 2022 and closes on Mar 22, 2022.

  • The minimum lot size for the IPO is 4000. The maximum lot size for the IPO is 4000.

  • For all category investors, the minimum application amount for this IPO is Rs. 108,000.0, the maximum value for this IPO is Rs 108,000.0.

  • This IPO will be allotted on Mar 25, 2022.

  • The refund will be credited to your account on Mar 28, 2022.

  • The allotted shares will be credited to your demat on Mar 29, 2022.

  • Evoq Remedies Ltd.’s shares listed on the stock exchanges on Mar 30, 2022.